Bio-Techne
TECH
#1412
Rank
A$19.12 B
Marketcap
$120.53
Share price
5.03%
Change (1 day)
11.10%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Operating Margin for Bio-Techne (TECH)

Operating Margin as of September 2024 (TTM): 29.79%

According to Bio-Techne's latest financial reports and stock price the company's current Operating Margin is 29.79%. At the end of 2023 the company had an Operating Margin of 29.79%.

Operating Margin history for Bio-Techne from 2001 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
202329.79%9.29%
202227.26%71.28%
202115.92%-57.48%
202037.43%138.57%
201915.69%-19.91%
201819.59%-1.5%
201719.89%-32.71%
201629.55%-13.3%
201534.09%-24.44%
201445.11%-12.8%
201351.73%0.33%
201251.56%-9.38%
201156.90%-2.15%
201058.15%-1.21%
200958.86%-1.5%
200859.76%3.58%
200757.69%5.16%
200654.86%-1.87%
200555.91%9.23%
200451.19%6.71%
200347.97%66.39%
200228.83%-30.44%
200141.44%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
16.19%-45.65%๐Ÿ‡บ๐Ÿ‡ธ USA
-67.49%-326.55%๐Ÿ‡บ๐Ÿ‡ธ USA
8.43%-71.70%๐Ÿ‡บ๐Ÿ‡ธ USA
21.11%-29.14%๐Ÿ‡บ๐Ÿ‡ธ USA
21.86%-26.62%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
14.99%-49.68%๐Ÿ‡บ๐Ÿ‡ธ USA
73.09% 145.35%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.